Research Leads to Rare ER+ Breast Cancer Mutations Insight
September 04, 2018
September 04, 2018
HOUSTON, Texas, Sept. 4 -- The Baylor College of Medicine issued the following news release:
Recent research and genomic studies have revealed a number of genes that accumulate somatic, or non-inherited, mutations and alterations in estrogen receptor positive (ER+) breast cancer. However, while a few alterations are quite common and relatively well understood, many genes are mutated in less than 5 percent of cases overall. As a result, little has been known about how uncommon mutati . . .
Recent research and genomic studies have revealed a number of genes that accumulate somatic, or non-inherited, mutations and alterations in estrogen receptor positive (ER+) breast cancer. However, while a few alterations are quite common and relatively well understood, many genes are mutated in less than 5 percent of cases overall. As a result, little has been known about how uncommon mutati . . .